Login to Your Account

Expansion Therapeutics draws $55.3M to back RNA therapies

By Michael Fitzhugh
Staff Writer

Wednesday, January 3, 2018

Expansion Therapeutics Inc. has raised a $55.3 million series A round to advance its portfolio of RNA-targeted small-molecule medicines to treat rare diseases.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription